OVARIAN SQUAMOUS CELL CARCINOMA
Clinical trials for OVARIAN SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Major trial aims to tame dozens of rare, neglected cancers with immune power combo
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control many different types of rare, advanced cancers that have limited treatment options. It enrolled over 800 adults whose cancer progressed after standard therapy. The g…
Matched conditions: OVARIAN SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 08:06 UTC
-
Immunotherapy tested for Tough-to-Treat ovarian cancer
Disease control OngoingThis study is testing the immunotherapy drug pembrolizumab for women with advanced or recurrent ovarian squamous cell carcinoma that cannot be removed by surgery. The goal is to see if the drug can shrink tumors and help patients live longer. The trial will enroll 21 participants…
Matched conditions: OVARIAN SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Niigata University Medical & Dental Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC